Skip to content

Clinical research on autologous platelet separation technology in open surgery for aortic dissection

Clinical research on autologous platelet separation technology in open surgery for aortic dissection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106868
Enrollment
Unknown
Registered
2025-07-31
Start date
2025-08-04
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type A aortic dissection

Interventions

Control group:None
Autologous platelet-rich plasmapheresis (APP) group:Autologous platelet-rich plasmapheresis

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old, gender not limited. 2.Undergo open surgery for aortic dissection. 3.Weight >=60kg, hemoglobin>120 g/L, platelet count>=120×10^9/L. 4.Understand the purpose of this trial and voluntarily participate, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Mechanical ventilation assistance is required before the operation. 2.Over 75 years old or under 18 years old. 3.Preoperative cardiogenic shock, cardiac arrest, severe hypotension (maintained with two or more vasoactive drugs), mixed venous oxygen saturation <75%, and mechanical circulatory support. 4.Combined with renal failure, blood purification treatment is required. 5.Combined with severe coagulation dysfunction or obvious bleeding tendency. 6.The known disease history of heparin-induced thrombocytopenia. 7.In a state of pregnancy or lactation. 8.Patients who have been diagnosed with severe mental illness and those who may affect the research results. 9.There are other circumstances that may affect the research results or safety, which shall be excluded by the researcher's judgment. 10.The researchers consider it unsuitable to participate in this experiment.

Design outcomes

Primary

MeasureTime frame
Red blood cell transfusion volume during the perioperative period of 24 hours;

Secondary

MeasureTime frame
Intraoperative blood loss;Perioperative usage of blood products;Postoperative complications;Drainage volume of intrathoracic drain;Length of stay in intensive care unit;Mortality;Rehospitalization;

Countries

China

Contacts

Public ContactChengliang Zhang

Xiangya Hospital, Central South University

zhangchengliang@csu.edu.cn+86 138 7485 8442

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026